
|Videos|July 13, 2020
Radioiodine Refractory Differentiated Thyroid Carcinoma
Author(s)Targeted Oncology
A key opinion leader discusses the evolving treatment landscape for radioiodine refractory differentiated thyroid carcinoma, with special consideration of the phase 3 SELECT trial.



































